
USD
+$0.00
(+0.00%
)At Close (As of Dec 9, 2025)
$31.75M
Market Cap
-
P/E Ratio
-0.1
EPS
$1.50
52 Week High
$0.20
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$48M |
| Total Revenue | $455K |
| Cost Of Revenue | $49M |
| Costof Goods And Services Sold | $49M |
| Operating Income | -$104M |
| Selling General And Administrative | $55M |
| Research And Development | $49M |
| Operating Expenses | $56M |
| Investment Income Net | - |
| Net Interest Income | $3.5M |
| Interest Income | $3.5M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1K |
| Income Before Tax | -$106M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$106M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$104M |
| Ebitda | -$104M |
| Net Income | -$106M |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$48M |
| Total Revenue | $455K |
| Cost Of Revenue | $49M |
| Costof Goods And Services Sold | $49M |
| Operating Income | -$104M |
| Selling General And Administrative | $55M |
| Research And Development | $49M |
| Operating Expenses | $56M |
| Investment Income Net | - |
| Net Interest Income | $3.5M |
| Interest Income | $3.5M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1K |
| Income Before Tax | -$106M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$106M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$104M |
| Ebitda | -$104M |
| Net Income | -$106M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New York, dedicated to developing innovative therapies for unmet medical needs in areas such as cardiovascular diseases, galactosemia, and diabetes-related complications. The company's robust pipeline focuses on novel compounds designed to address significant health challenges, showcasing a commitment to cutting-edge research and patient-centric solutions. As it advances through clinical trials, Applied Therapeutics is poised to become a transformative force in the treatment landscape, aiming to significantly enhance patient outcomes in its targeted therapeutic areas.